Drug & supplement interaction

Fucus Vesiculosus + Enasidenib

Enasidenib brand name: Idhifa.

Minor Interaction
Medically reviewed by · Updated September 2026
The bottom line Minor

Enasidenib falls into 4 drug categories that Fucus Vesiculosus can interact with; the most serious is rated minor. Theoretically, concomitant use of Fucus vesiculosus with CYP2D6 substrates might alter the effects of these substrates.

Read the full interaction report
SeverityMinor
LikelihoodPossible
Interactions4
EvidenceD
What do Severity, Likelihood & Evidence mean?
Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Fucus Vesiculosus and Enasidenib

These two interact in 4 distinct ways. Each one is explained separately below.

Why Are There 4 Interactions?

Fucus Vesiculosus interacts with whole categories of medication. Enasidenib falls into 4 of those categories, so it can interact with Fucus Vesiculosus in 4 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Minor).

Minor

CYTOCHROME P450 2D6 (CYP2D6) SUBSTRATES

1 of 4

Why this applies to Enasidenib

Enasidenib falls under CYTOCHROME P450 2D6 (CYP2D6) SUBSTRATES — the group Fucus Vesiculosus interacts with.

Theoretically, concomitant use of Fucus vesiculosus with CYP2D6 substrates might alter the effects of these substrates.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, both inhibits and induces CYP2D6. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the honest picture: Enasidenib (Idhifa) is partly handled by a liver enzyme called CYP2D6. Bladderwrack contains a compound called fucoidan that, in test-tube studies only, has both sped up and slowed down that same enzyme. So in theory it could nudge your enasidenib levels up or down, but nobody actually knows which direction it would go in a real person.

The good news is this has never been reported in humans, and the lab signal is weak and mixed. Still, with a leukemia drug like this, you don't want to gamble on too much (more nausea, diarrhea, or liver effects) or too little (weaker cancer control). Please run any bladderwrack supplement by your oncology team before starting it.

Contact Dr. Brian directly if you have additional questions on this interaction
References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.
Minor

CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES

2 of 4

Enasidenib also falls under CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES.

Theoretically, concomitant use of Fucus vesiculosus with CYP2C9 substrates might increase the risk for adverse effects.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, inhibits CYP2C9. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the gist: bladderwrack contains a compound called fucoidan that, in lab dishes, seems to slow down an enzyme called CYP2C9. Since your body uses that same enzyme to help clear enasidenib (Idhifa), the theory is that adding bladderwrack could let the drug build up a bit, which might mean more of its known side effects like nausea, diarrhea, low appetite, or changes in your blood counts and bilirubin.

I want to be straight with you though: this is only a test-tube finding, and it has never actually been reported in real people. So the chance of a meaningful problem is low. That said, enasidenib is a serious cancer medicine, so please don't start bladderwrack without first running it past your oncology team or pharmacist.

Contact Dr. Brian directly if you have additional questions on this interaction
References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.
Minor

CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES

3 of 4

Enasidenib also falls under CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES.

Theoretically, concomitant use of Fucus vesiculosus with CYP3A4 substrates might increase the risk for adverse effects.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, inhibits CYP3A4. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the gist for Idhifa (enasidenib). Your body partly clears this leukemia drug using a liver enzyme called CYP3A4. Bladderwrack contains a compound (fucoidan) that, in test-tube studies, slowed that enzyme down. If that happened in real life, your enasidenib could clear a bit more slowly and build up, which in theory might mean more side effects like nausea, diarrhea, low appetite, or rising bilirubin levels.

I want to be honest about how soft this is. The concern comes only from lab research, not from anything seen in actual patients, and it's rated a minor interaction. Still, enasidenib is a serious cancer therapy, so please don't add bladderwrack without first running it past your oncology team or pharmacist.

Contact Dr. Brian directly if you have additional questions on this interaction
References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.
Minor

CYTOCHROME P450 2C8 (CYP2C8) SUBSTRATES

4 of 4

Enasidenib also falls under CYTOCHROME P450 2C8 (CYP2C8) SUBSTRATES.

Theoretically, concomitant use of Fucus vesiculosus with CYP2C8 substrates might increase the risk for adverse effects.
In vitro research shows that fucoidan, a constituent of Fucus vesiculosus, inhibits CYP2C8. This interaction has not been reported in humans.
Severity Minor Likelihood Possible Evidence D

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.

Dr. Brian Staiger, PharmD, BCPS
Dr. Brian Staiger explains PharmD, Clinical Pharmacist

Here's the short version: bladderwrack contains a compound called fucoidan, and in lab dish studies only it slowed down an enzyme named CYP2C8. Your leukemia medicine, enasidenib (Idhifa), is partly cleared by that same enzyme. So in theory, if that enzyme is held back, a bit more enasidenib could linger in your body, which might nudge up side effects like nausea, diarrhea, low appetite, or changes in your blood counts and bilirubin.

I want to be honest about the strength here: this has never actually been seen in people, only in a test tube, and it's rated as a minor concern. Still, enasidenib is a serious cancer drug, so don't add bladderwrack on your own. Please run it by your oncology team or pharmacist first.

Contact Dr. Brian directly if you have additional questions on this interaction
References
  1. Mathew L, Burney M, Gaikwad A, et al. Preclinical evaluation of safety of fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus for use in cancer treatment. Integr Cancer Ther 2017;16(4):572-84.

What These Ratings Mean

Every interaction above is graded three ways — here’s the key to each label.

Severity how clinically significant the interaction is
Major

Clinically significant. Avoid the combination, or use only under close professional supervision.

Moderate

Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.

Minor

Generally not serious. Be aware of it and mention it to your pharmacist.

Likelihood how strong the evidence is that the interaction actually happens in people
  • LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
  • ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
  • UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Evidence the quality of the studies behind the rating (graded A–D)
  • AHigh-quality meta-analysis (quantitative systematic review).
  • BCase-control study.
  • CConsensus.
  • DAnecdotal evidence.

These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.

Keep it in perspective

Fucus Vesiculosus Also Interacts With Other Medications

Fucus Vesiculosus has 23 moderate, 867 minor known drug interactions in our database — the Enasidenib one above is among them. If you take anything else, check it against the full list below.

Moderate 23 Minor 867 No known interaction 1,940 (incl. Enasidenib)
Taking anything else?

Check Another of Your Medications Against Fucus Vesiculosus

Covers the 2,830 medications we’ve checked against Fucus Vesiculosus. Pick one to open its full report.

Everything else you take

See Every Supplement That Interacts With Enasidenib

This page covers Fucus Vesiculosus only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Enasidenib page lists 203 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), 1,3-dmaa (moderate) and Acacia Rigidula (moderate).

By severity: 3 major · 156 moderate · 44 minor.

From our pharmacist’s overview on the Enasidenib page

“Anyone taking enasidenib (Idhifa) for acute myeloid leukemia should treat this supplement list with genuine care, beginning with the major-rated entries: grapefruit, St. John's wort, and activated charcoal.”

Reviewed by 2 · Jul 18, 2026

Open the Enasidenib interaction page

How much people look this up

Where Fucus Vesiculosus and Enasidenib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Fucus Vesiculosus
Steady interest

#1,037 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Enasidenib
Steady interest

#2,270 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Supplement

About Fucus Vesiculosus

What is Fucus Vesiculosus?

Fucus Vesiculosus
  • Thyroid support
  • Iodine source
  • Weight management
  • Joint and skin care (topical)
  • Constipation and digestive support

Fucus vesiculosus (bladderwrack) is a brown seaweed rich in iodine that has been used traditionally for thyroid concerns, weight, and skin. There is little solid human evidence to support most of these uses, and its high and variable iodine content can actually harm the thyroid. Talk to a pharmacist or doctor before using it, especially if you have a thyroid condition.

Read the full Fucus Vesiculosus monograph & all interactions
Medication

About Enasidenib

What Is Enasidenib Used For?

Brand name: Idhifa

Idhifa (enasidenib) is used to treat adult patients with acute myeloid leukemia (AML) — a fast-moving cancer of the blood and bone marrow — whose disease has come back after treatment (relapsed) or has stopped responding to treatment (refractory). It is specifically for patients whose leukemia has a mutation in the IDH2 gene, which must be confirmed by an FDA-approved test before starting therapy.

See full Enasidenib drug information
Keep checking

Other Drugs & Fucus Vesiculosus

Browse every other medication we’ve checked against Fucus Vesiculosus — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
23Moderate
867Minor
1,939No known interaction
23 Moderate 867 Minor 1,939 No interaction
Moderate

23 interactions

Minor

867 interactions

Showing 60 of 867 minor interactions — see all 867 on the Fucus Vesiculosus page.

No interaction 1,939 drugs checked — show the list

We also checked Fucus Vesiculosus against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 1,939 medications checked with no known interaction — see the full Fucus Vesiculosus list.

See the full Fucus Vesiculosus interactions page
See every supplement checked against Enasidenib, ranked by severity
Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Fucus Vesiculosus monograph › Uses, safety, and every drug interaction in one place Enasidenib supplement interactions › Every supplement checked against Enasidenib, ranked by severity Enasidenib drug information › The full plain-English guide to this medication Supplement interaction checker › Check any supplement or product against your medications Browse medications A–Z › Every drug we've checked against herbs & supplements Ask a pharmacist › Free, personal answer from our licensed team
Pharmacist Counseling Corner

Taking Fucus Vesiculosus and Enasidenib Together: Common Questions

Can you take Fucus Vesiculosus with Enasidenib?
There is only a minor interaction, which is usually not serious. Read the full details on this page and confirm with your pharmacist before combining them.
Why are there 4 interactions listed for Fucus Vesiculosus and Enasidenib?
Enasidenib belongs to more than one drug category, and Fucus Vesiculosus interacts with each of those categories a little differently. We list every one so nothing is missed — your overall risk is driven by the most serious of them.
How serious is the Fucus Vesiculosus and Enasidenib interaction?
We rate it Minor. This interaction is generally not clinically significant, but it remains worth noting and discussing with your pharmacist.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Enasidenib and Fucus Vesiculosus?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.